Latest: Abzena Launches EpiScreen® 2.0 Immunogenicity Platform | Learn more
- About
- Main Menu
- Main Menu
- Leadership Team
- Our History
- Locations
- Capabilities
- Main Menu
- Main Menu
- Bioconjugates & Chemistry
- Biologics
- Resources
- Careers
- Contact
Create new potential in the ADC oncology space with deep insight and understanding into the innovative field of oligonucleotide bioconjugates, focusing upon their design, development, analysis and manufacture.
Access the full on-demand webinar from our team of industry experts as they take an in-depth look at their area of specialism.